These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 27745640)

  • 1. Universal immunohistochemical screening of sebaceous neoplasms for Muir-Torre syndrome: Putting the cart before the horse?
    Kim RH; Nagler AR; Meehan SA
    J Am Acad Dermatol; 2016 Nov; 75(5):1078-1079. PubMed ID: 27745640
    [No Abstract]   [Full Text] [Related]  

  • 2. Sebaceous Neoplasms.
    Flux K
    Surg Pathol Clin; 2017 Jun; 10(2):367-382. PubMed ID: 28477886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of the current medical literature and assessment of current utilization patterns regarding mismatch repair protein immunohistochemistry in cutaneous Muir-Torre syndrome-associated neoplasms.
    Lee JB; Litzner BR; Vidal CI
    J Cutan Pathol; 2017 Nov; 44(11):931-937. PubMed ID: 28749576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Considerations on the performance of immunohistochemistry for mismatch repair gene proteins in cases of sebaceous neoplasms and keratoacanthomas with reference to Muir-Torre syndrome.
    Fernandez-Flores A
    Am J Dermatopathol; 2012 Jun; 34(4):416-22. PubMed ID: 22123265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sebaceous neoplasms and the Muir-Torre syndrome.
    Elston DM
    J Am Acad Dermatol; 2023 Dec; 89(6):1123. PubMed ID: 37172735
    [No Abstract]   [Full Text] [Related]  

  • 6. The DNA mismatch repair system in sebaceous tumors: an update on the genetics and workup of Muir-Torre syndrome.
    Dany M
    Cutis; 2020 Mar; 105(3):E34-E37. PubMed ID: 32352449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Female patient with Muir-Torre syndrome].
    Negraszus N; Jöhrens K; Bertelmann E
    Ophthalmologe; 2010 Nov; 107(11):1059-62. PubMed ID: 20393721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muir-Torre Syndrome / Turcot Syndrome overlap? A patient with sebaceous carcinoma, colon cancer, and a malignant astrocytoma.
    Kleinerman R; Marino J; Loucas E
    Dermatol Online J; 2012 May; 18(5):3. PubMed ID: 22630573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA mismatch repair defects and microsatellite instability status in periocular sebaceous carcinoma.
    Rajan Kd A; Burris C; Iliff N; Grant M; Eshleman JR; Eberhart CG
    Am J Ophthalmol; 2014 Mar; 157(3):640-7.e1-2. PubMed ID: 24321472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of Muir-Torre syndrome with a keratoacanthoma and sebaceous neoplasms: Clinicopathological features and a speculation on the pathogenesis of cutaneous tumor type.
    Takayama E; Yoshioka A; Takai T; Goto K
    J Dermatol; 2021 May; 48(5):690-694. PubMed ID: 33523490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome.
    Jessup CJ; Redston M; Tilton E; Reimann JD
    Hum Pathol; 2016 Mar; 49():1-9. PubMed ID: 26826402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Muir-Torre syndrome and Turcot syndrome].
    Velter C; Caussade P; Fricker JP; Cribier B
    Ann Dermatol Venereol; 2017; 144(8-9):525-529. PubMed ID: 28256262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deceptively Innocent Façade of Sebaceous Carcinoma in Muir-Torre Syndrome.
    Cox SV; Smith J
    Dermatol Surg; 2021 Jun; 47(6):828-829. PubMed ID: 33038102
    [No Abstract]   [Full Text] [Related]  

  • 14. The significance of DNA mismatch repair genes in the diagnosis and management of periocular sebaceous cell carcinoma and Muir-Torre syndrome.
    Gaskin BJ; Fernando BS; Sullivan CA; Whitehead K; Sullivan TJ
    Br J Ophthalmol; 2011 Dec; 95(12):1686-90. PubMed ID: 21979897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Genetics of Sebaceous Neoplasia.
    North JP
    Surg Pathol Clin; 2021 Jun; 14(2):273-284. PubMed ID: 34023105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical follow-up and presence of visceral tumors in 12 patients with sebaceous gland tumors].
    Mercader P; García-Melgares ML; Roche E; Sánchez-Carazo JL; Alegre-de Miquel V
    Actas Dermosifiliogr; 2008 Sep; 99(7):532-9. PubMed ID: 18682166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muir-Torre syndrome: Facts and controversies.
    Ko CJ
    Clin Dermatol; 2010; 28(3):324-9. PubMed ID: 20541687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple benign adnexal tumours: Anything but benign.
    McCarthy RL; Thomas CL; Isaacs F
    Australas J Dermatol; 2019 Aug; 60(3):234-236. PubMed ID: 30671930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Muir-Torre syndrome--a phenotypic variant of Lynch syndrome].
    Kacerovská D; Kazakov DV; Cerná K; Hadravský L; Michal M; Dostál J; Skálová A; Michal M
    Cesk Patol; 2010 Oct; 46(4):86-94. PubMed ID: 21313735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm.
    Abbas O; Mahalingam M
    J Cutan Pathol; 2009 Jun; 36(6):613-9. PubMed ID: 19515040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.